Lorusso, D., Damian, S., Colombo, I., Wang, E. W., Velden, M. V. D., Richards, E. C., Kinder, M., Liu, Q., Kristeleit, R. (2025). Interim safety and antitumor activity data from a phase 1 study of INCB123667, a selective CDK2 inhibitor, in patients with metastatic recurrent endometrial cancer.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.5603